Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSutro Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.91 | -$0.81 | -$0.85 |
| Q2 2025 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q3 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q4 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q1 2026 | 1 | -$0.69 | -$0.69 | -$0.69 |
| Q2 2026 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q3 2026 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q4 2026 | 1 | -$0.63 | -$0.63 | -$0.63 |
Sutro Biopharma, Inc. Earnings Date And Information
Sutro Biopharma, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.59 earnings per share for the quarter, topping analysts' consensus estimates of $-0.74 by $0.15. The company had revenue of 8.52 M for the quarter and had revenue of 153.73 M for the year. Sutro Biopharma, Inc. has generated $-2 earnings per share over the last year ($-1.78 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. Sutro Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
Sutro Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.74 | -$0.59 | 0.15 | $15.29 M | $8.52 M |
| 08/13/2024 | Q2 2024 | -$0.59 | $21.02 M | $25.71 M | ||
| 05/13/2024 | Q1 2024 | -$0.92 | -$0.95 | -0.03 | $13.01 M | |
| 03/25/2024 | Q4 2023 | -$0.82 | $0.51 | 1.33 | $113.72 M | |
| 11/13/2023 | Q3 2023 | -$0.76 | -$0.81 | -0.05 | $13.01 M | $16.92 M |
| 08/10/2023 | Q2 2023 | -$0.64 | $12.56 M | $10.41 M | ||
| 05/15/2023 | Q1 2023 | -$0.83 | -$0.85 | -0.02 | $12.67 M | |
| 03/30/2023 | Q4 2022 | -$0.64 | -$0.65 | -0.01 | $8.63 M | |
| 11/08/2022 | Q3 2022 | -$0.15 | -$0.34 | -0.19 | $35.71 M | $25.15 M |
| 08/08/2022 | Q2 2022 | -$0.74 | -$0.55 | 0.19 | $16.01 M | $28.10 M |
| 05/09/2022 | Q1 2022 | -$0.79 | -$0.84 | -0.05 | $5.90 M | |
| 02/28/2022 | Q4 2021 | -$0.67 | -$0.83 | -0.16 | $10.65 M | |
| 11/09/2021 | Q3 2021 | -$0.67 | -$0.67 | 0 | $8.97 M | $8.52 M |
| 08/06/2021 | Q2 2021 | -$0.42 | -$0.13 | 0.29 | $13.29 M | $28.05 M |
| 05/06/2021 | Q1 2021 | -$0.61 | -$0.66 | -0.05 | $14.66 M | |
| 03/17/2021 | Q4 2020 | -$0.56 | -$1.61 | -1.05 | $8.28 M | |
| 11/04/2020 | Q3 2020 | -$0.44 | $0.46 | 0.9 | $7.29 M | $17.82 M |
| 08/05/2020 | Q2 2020 | -$0.59 | $1.00 | 1.59 | $6.96 M | $9.47 M |
| 05/08/2020 | Q1 2020 | -$0.69 | -$0.84 | -0.15 | $7.15 M | |
| 03/13/2020 | Q4 2019 | -$0.77 | -$0.64 | 0.13 | $11.31 M |
Sutro Biopharma, Inc. Earnings: FAQ's
When is Sutro Biopharma, Inc.'s earnings date?
Sutro Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
Did Sutro Biopharma, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Sutro Biopharma, Inc. (:STRO) reported $-0.59 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.74 by $0.15.
How can I listen to Sutro Biopharma, Inc.'s earnings conference
call?
The conference call for Sutro Biopharma, Inc.'s latest earnings report can be listened to online.
How can I read Sutro Biopharma, Inc.'s conference call transcript?
The conference call transcript for Sutro Biopharma, Inc.'s latest earnings report can be read online.
How much revenue does Sutro Biopharma, Inc. generate each year?
Sutro Biopharma, Inc. (:STRO) has a recorded annual revenue of $153.73 M.
How much profit does Sutro Biopharma, Inc. generate each year?
Sutro Biopharma, Inc. (:STRO) has a recorded net income of $153.73 M. Sutro Biopharma, Inc. has generated $-1.78 earnings per share over the last four quarters.
What is Sutro Biopharma, Inc.'s price-to-earnings ratio?
Sutro Biopharma, Inc. (:STRO) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is -0.11.